121
Participants
Start Date
September 30, 2006
Primary Completion Date
April 30, 2010
Study Completion Date
May 31, 2010
cyclosporine or tacrolimus
Cyclosporine and tacrolimus are provided by the sites and dosed to achieve a target trough level determined by the investigator; therefore, form, dosage, and frequency are site and patient specific. Duration should be 52 weeks on-therapy.
sirolimus
Oral (1 and 2 mg) tablets, dosing should be once daily to achieve a target trough level of 7- 15 ng/mL. Duration should be 52 weeks on-therapy.
Pfizer Investigational Site, Epsom
Pfizer Investigational Site, Darlinghurst
Pfizer Investigational Site, Bern
Pfizer Investigational Site, La Coru?a
Pfizer Investigational Site, Pittsburgh
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, Norfolk
Pfizer Investigational Site, Madrid
Pfizer Investigational Site, Tampa
Pfizer Investigational Site, Santander
Pfizer Investigational Site, Seville
Pfizer Investigational Site, Valencia
Pfizer Investigational Site, Rochester
Pfizer Investigational Site, Houston
Pfizer Investigational Site, New York
Pfizer Investigational Site, Vienna
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Québec
Pfizer Investigational Site, Sainte-Foy
Pfizer Investigational Site, Auckland
Pfizer Investigational Site, L'Hospitalet de Llobregat
Pfizer Investigational Site, Barcelona
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY